CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Bilthoven Biologicals

For profitWebsite ↗

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

May 1, 2016

Timeline

2010s

Jun 1, 2012
Bilthoven Biologicals— Founded

Drugs by trial phase (1 distinct, 1 trials)

Phase 3 (1 own, 0 via acquisition)

bivalent oral polio vaccine (bopv), type 1 and type 3

Indications

Studied for

Poliomyelitis

Recent trials (1)

NCT02766816Lead sponsorPhase 3May 1, 2016

Details

Founded: Bilthoven, NL Jun 1, 2012
Last known activity: May 1, 2016